Rockefeller Capital Management L.P. Astrazeneca PLC Transaction History
Rockefeller Capital Management L.P.
- $42.4 Billion
- Q2 2025
A detailed history of Rockefeller Capital Management L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 739,684 shares of AZN stock, worth $62.5 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
739,684
Previous 287,986
156.85%
Holding current value
$62.5 Million
Previous $20.1 Million
156.85%
% of portfolio
0.12%
Previous 0.05%
Shares
30 transactions
Others Institutions Holding AZN
# of Institutions
1,416Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.39 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.48 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.9 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.65 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.63 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $262B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...